You have 9 free searches left this month | for more free features.

ON 01910

Showing 1 - 25 of 55

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in

Not yet recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +4 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Feb 28, 2023

Recessive Dystrophic Epidermolysis Bullosa Trial in Philadelphia (Rigosertib Sodium, Quality-of-Life Assessment)

Recruiting
  • Recessive Dystrophic Epidermolysis Bullosa
  • Rigosertib Sodium
  • Quality-of-Life Assessment
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Aug 31, 2021

Myelodysplastic Syndrome (MDS) Trial run by the NHLBI (ON 01910 Na)

Completed
  • Myelodysplastic Syndrome (MDS)
  • ON 01910 Na
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019

Phase II Cont. IV of ON 01910.Na in MDS w/ Trisomy 8/Intermed-1,

Completed
  • Myelodysplastic Syndromes
    • Stanford, California
      Stanford University School of Medicine
    Mar 23, 2020

    Leukemia, Myelofibrosis, Anemia Trial in Houston (Rigosertib, Questionnaire)

    Terminated
    • Leukemia
    • +3 more
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Aug 5, 2020

    MDS Trial in France, Germany, United States (Oral rigosertib)

    Completed
    • Myelodysplastic Syndromes
    • Oral rigosertib
    • Stanford, California
    • +13 more
    Jun 15, 2021

    Lymphoma, Mantle-cell, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Hairy Cell Trial run by the NHLBI (ON01910 Na)

    Completed
    • Lymphoma, Mantle-cell
    • +4 more
    • ON01910 Na
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Nov 30, 2019

    Myelodysplastic Syndrome Trial in New York (rigosertib)

    Withdrawn
    • Myelodysplastic Syndrome
    • New York, New York
      Columbia University Medical Center
    Jun 29, 2020

    Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in France, United States (oral

    Completed
    • Myelodysplastic Syndrome
    • +2 more
    • Gilbert, Arizona
    • +12 more
    Jun 15, 2021

    MDS, MDS, RAEB Trial in Worldwide (ON 01910.Na)

    Completed
    • Myelodysplastic Syndromes
    • +3 more
    • ON 01910.Na
    • Scottsdale, Arizona
    • +86 more
    Jun 29, 2020

    Right Portal Vein Diameter

    Completed
    • Intrauterine Growth Retardation (IUGR)
    • Ultrasound
    • Poitiers, France
      C.H.U. de Poitiers
    Oct 10, 2022

    Epidermolysis Bullosa Dystrophica, Squamous Cell Carcinoma Trial in Salzburg (Rigosertib Oral Capsules / Rigosertib Intravenous)

    Recruiting
    • Epidermolysis Bullosa Dystrophica
    • Squamous Cell Carcinoma
    • Rigosertib Oral Capsules / Rigosertib Intravenous
    • Salzburg, Austria
      EB House Austria/Dept. of Dermatology University Hospital
    Nov 3, 2022

    Chronic Pelvic Pain, Myofascial Trigger Point Pain Trial in Lahore (TENS, Myofascial trigger point release)

    Recruiting
    • Chronic Pelvic Pain
    • Myofascial Trigger Point Pain
    • TENS
    • Myofascial trigger point release
    • Lahore, Punjab, Pakistan
      Jinnah Hospital Lahore
    May 9, 2023

    NSCLC, Adenocarcinoma, Stage IV Trial in New York (Rigosertib, Nivolumab)

    Recruiting
    • Non-small Cell Lung Cancer
    • +2 more
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Feb 8, 2022

    Myelodysplastic Syndrome, MDS, Refractory Anemia With Excess Blasts Trial in Worldwide (rigosertib, Any approved or

    Terminated
    • Myelodysplastic Syndrome
    • +3 more
    • La Jolla, California
    • +157 more
    Sep 22, 2022

    MDS, Refractory Anemia With Excess Blasts, Chronic Myelomonocytic Leukemia Trial in Worldwide (rigosertib sodium)

    Completed
    • Myelodysplastic Syndromes
    • +3 more
    • rigosertib sodium
    • Stanford, California
    • +34 more
    Jun 29, 2020

    Chronic Ulcer of Leg or Foot, Diabetic Foot Ulcer, Arterial Ulcer Trial in Montpellier (CACIPLIQ20®)

    Recruiting
    • Chronic Ulcer of Leg or Foot
    • +3 more
    • CACIPLIQ20®
    • Montpellier, France
      Réseau Cicat-Occitanie
    Feb 24, 2022

    Methylation, mIcrobiome, NUtritional sTatus, and dEvelopment of

    Not yet recruiting
    • Stunting
    • +4 more
      • (no location specified)
      Mar 9, 2023

      Tension, Headache Trial in Lafayette (HLNatural Tension)

      Completed
      • Tension
      • Headache
      • HLNatural Tension
      • Lafayette, California
        Hawthorne Effect, Inc.
      Nov 5, 2021

      Vaginal Atrophy Trial in Dallas (IntraGen RF, DiVA)

      Completed
      • Vaginal Atrophy
      • IntraGen RF
      • +2 more
      • Dallas, Texas
        University of Texas Southwestern Medical Center
      Dec 9, 2022

      Acute Myelocytic Leukemia, Acute Lymphocytic Leukemia, Chronic Myelocytic Leukemia Trial in New York (ON 01910.Na)

      Completed
      • Acute Myelocytic Leukemia
      • +4 more
      • ON 01910.Na
      • New York, New York
        Mount Sinai Medical Center
      Jan 9, 2018

      Helicobacter Pylori Infection Trial in Kaohsiung (rabeprazole+3 antibiotics, rabeprazole+bismuth+2 antibiotics,

      Unknown status
      • Helicobacter Pylori Infection
      • rabeprazole+3 antibiotics
      • +2 more
      • Kaohsiung, Taiwan
        Kaohsiung Veterans General Hospital
      Mar 18, 2021

      Hypertension, Genetics Hypertension Trial in Boston (Eplerenone vs Amlodipine)

      Recruiting
      • Hypertension
      • Genetics Hypertension
      • Eplerenone vs Amlodipine
      • Boston, Massachusetts
        Brigham and Women's Hospital
      Nov 11, 2021

      Childhood Hepatocellular Carcinoma, Childhood Malignant Liver Tumor, Fibrolamellar Carcinoma Trial in Worldwide (drug, other,

      Recruiting
      • Childhood Hepatocellular Carcinoma
      • +4 more
      • Birmingham, Alabama
      • +201 more
      Jan 30, 2023

      Ovarian Cancer Trial in Indianapolis (ON 01910.Na)

      Completed
      • Ovarian Cancer
      • ON 01910.Na
      • Indianapolis, Indiana
        St. Vincent Gynecologic Oncology
      Jun 22, 2017